Drugs & Targets Bayer’s Aliqopa gets FDA accelerated approval for relapsed follicular lymphoma September 15, 2017Vol.43 No.34
Drugs & Targets Cemiplimab receives FDA breakthrough designation for advanced cutaneous squamous cell carcinoma September 15, 2017Vol.43 No.34
In Brief Marcus named associate director for basic research, shared resources at Winship September 15, 2017Vol.43 No.34
